Aurinia Pharmaceuticals Inc (AUPH)
Working Capital Ratio
55.72%
Quarterly · Period ending:
AUPH Working Capital Ratio
Latest reported55.72%period ending
Latest reported55.72%period ending
AUPH Quarterly Working Capital Ratio (0.00% → 55.72%)
Quarterly working capital ratio
High-resolution chart · PNG
AUPH working capital ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Working Capital Ratio |
|---|---|
| 55.7178% | |
| 54.377% | |
| 52.9869% | |
| 68.72% | |
| 65.8036% | |
| 66.823% | |
| 63.3499% | |
| 65.8674% | |
| 63.5615% | |
| 63.3274% | |
| 63.4257% | |
| 63.5263% | |
| 64.5374% | |
| 84.4699% | |
| 84.1932% | |
| 85.5914% | |
| 86.813% | |
| 87.5475% | |
| 86.9906% | |
| 81.0079% | |
| 82.9409% | |
| 84.1797% | |
| 83.5589% | |
| 83.9742% | |
| 88.3493% | |
| 90.0775% | |
| 93.6914% | |
| 82.9486% | |
| 86.7665% | |
| 88.1016% | |
| 86.0993% | |
| 86.9799% | |
| 88.6021% | |
| 88.8107% | |
| 88.0193% | |
| 89.0898% | |
| 90.8874% | |
| 89.2874% | |
| 58.754% | |
| 37.7654% | |
| 33.0617% | |
| 26.8839% | |
| 38.4812% | |
| 44.786% | |
| 50.8348% | |
| 56.5989% | |
| 58.641% | |
| 61.2217% | |
| 59.6205% | |
| 61.698% | |
| -17.0569% | |
| -9.3954% | |
| -97.8656% | |
| -105.4207% | |
| -77.5979% | |
| 2.7566% | |
| 21.1291% | |
| 42.5852% | |
| 43.2294% | |
| 50.6201% | |
| 49.6556% | |
| 51.4241% | |
| 50.9141% | |
| 49.4047% | |
| 37.3969% | |
| 33.4421% | |
| 22.6168% | |
| 30.1861% | |
| 37.1741% | |
| 25.7644% | |
| 47.3292% | |
| 53.5726% | |
| 63.6852% | |
| 62.6508% | |
| 57.6125% | |
| 68.2175% | |
| 69.2952% | |
| 75.499% | |
| 54.5141% | |
| 63.0568% | |
| 68.3468% | |
| 68.0812% | |
| 68.6448% | |
| 76.8105% | |
| 73.5033% | |
| 76.7676% | |
| 76.8637% | |
| 78.642% | |
| 81.9928% | |
| 78.6314% | |
| 78.9306% | |
| 82.6041% | |
| 81.0366% | |
| 78.1503% | |
| 80.5813% | |
| 84.2279% | |
| 84.9799% | |
| 85.8738% | |
| 80.1362% | |
| 75.4835% |